A B S T R A C T We asked whether binding of human immunoglobulin (Ig)G antibody reacting with Raji cells could be distinguished from binding of IgG immune complexes. Using a standard Raji assay employing 125I-IgG goat anti-human Fcy, we found that digestion of Raji cells with pronase reduced by 95% their ability to bind complement-fixed aggregated human y globulin and complement-fixed tetanus toxoid-antitetanus toxin complexes. However, binding at 37°C of IgG from the sera of 16 patients with systemic lupus erythematosus (SLE) to pronasedigested Raji cells was reduced much less consistently and extensively (9-100% reduction; mean reduction of 51%). In more detailed studies of two SLE sera, sucrose density gradient centrifugation showed that >50% of the IgG binding to undigested Raji cells sedimented in the 7S region. Pepsin digestion ofimmunoglobulin fractions from four SLE sera caused a reduction in SLE IgG binding to undigested Raji cells when detected with 125I anti-Fcy, but an increase when binding was detected with '25I-anti-Fab, suggesting that substantial SLE IgG can bind through F(ab')2 regions. Binding of IgG from SLE sera was not directed at neoantigenic sites induced by pronase digestion because binding activity was adsorbed with undigested cells as readily as with digested cells. Moreover, sera from 10 SLE patients that had negative Raji assays contained no IgG that bound to pronase-digested Raji cells. We conclude that much of the IgG bound at 37°C to Raji cells from the sera of many patients with SLE does not represent immune complexes but is probably antibody directed toward sites on the Raji cell.
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INTRODUCTION
The Burkitt lymphoma-derived human lymphoblastoid cell line, Raji, which bears receptors on its plasma membrane for immunoglobulin (Ig)'G and several complement components including C3-C3b, C3d, Clq, has been used for the past several years to detect small amounts of circulating immune complexes (IC) (1) . The receptors for C3 have been thought to be primarily involved in IC binding (1) , although recent evidence suggests that Clq receptors may play a larger role (2) . Binding to the Fc receptors has been shown to be negligible (3) . A clinical assay for circulating IC using this cell line has enjoyed wide use (1) . A number of diseases have been shown to be associated with circulating IC, and clinical correlation of disease activity with Raji cell reactivity has been demonstrated in some cases (for review, cf. 4). The cell line has additionally been used to purify IC for purposes ofantigen identification (5) .
In the course of evaluating a number of antisera for usefulness in detecting IC on the surface of Raji cells, we discovered that goat IgG antibodies directed against human y, u, and a chains were all capable of detecting material adsorbed to Raji cells from sera from patients with systemic lupus erythematosus (SLE). Because antibodies to a number of lymphocyte determinants are known to circulate in the sera of these patients (6) it seemed reasonable to consider that such antibodies might be responsible for at least a part ofthe Raji cell activity.
Such antilymphocyte antibodies, detected by cyto-toxicity, had been thought to be chiefly ofthe IgM class and to react with lymphocytes in the cold (7, 8) . Early evidence indicated that these antibodies were not detected by the Raji assay (1). But sucrose density gradient centrifugation of SLE sera has demonstrated that much of the Raji-binding material in SLE serum has a sedimentation coefficient equivalent to that of monomeric IgG (9) . Moreover, IgG antilymphocyte antibodies capable of binding at 370C have recently been described in the sera of patients with SLE (6) . The present study was undertaken, therefore, to evaluate the extent to which the Raji-binding material in the sera of patients with SLE is antibody directed against determinants on the Raji cell, as opposed to IC that bind to the receptors present on the Raji cell. Our results indicate that a considerable amount of the reactivity in the sera of these patients is, in fact, Rajidirected antibody. ) by ion exchange chromatography on DEAE cellulose, and was dialyzed against phosphate-buffered saline (PBS) (0.15 M NaCl, 0.02 M sodium phosphate, pH 7.0). Aggregated human IgG (AHG) was prepared by incubating a 6.5-mg/ml solution for 70 min in a 63°C water bath. Aliquots were stored at -700C for up to 4 mo and thawed on the day of each experiment. The preparations were centrifuged at 2,100 g for 15 min immediately before use. After fixation of complement aggregates stored in this manner showed negligible variation in their ability to bind to complement receptors on Raji cells. To prepare complement-fixed aggregates, 25 ,tl of AHG were incubated for 30 min at 370C with 25 ,l of NHS and 50 ,lp of 0.15 M NaCl. Of this material, 25 ,ul was assayed for binding to Raji cells. In the absence of complement (NHS) or in the presence of heatinactivated complement, AHG binding was negligible (Fig. 1) .
METHODS
Pronase (Sigma Chemical Co., P5130, lot No. 19C-0388, 4.4 U/ml) was dissolved immediately before use in spinner's medium. Raji cells at 107/ml were incubated with pronase for 25 min at 37°C and washed free of the enzyme by centrifugation and resuspension in spinner's medium. The cell concentration was readjusted to 107/ml. Viability and cell yield were unchanged by pronase digestion; cellular debris, however, diminished.
Tetanus toxoid (4 mg/ml) and human globulin antitetanus toxin (145 mg/ml) were obtained from the Massachusetts Public Health Biologic Laboratories, Boston, Mass. IC were prepared by incubating 0.25 ml of antitetanus toxin with an equal volume of tetanus toxoid serially diluted in PBS for 1 h at 370C and for 18 h at 40C. Insoluble complexes were removed by centrifugation at 2,100 g for 30 min. 100 pA of the supernates were incubated with 600 ,ul of normal saline and 100 ,ul NHS, the source of complement, for 30 min at 370C.
The binding of these complement-fixed IC to Raji cells was then evaluated by incubating 25 ,lI of these solutions with 2 x 106 Raji cells and proceeding with the Raji assay. Maximum binding was obtained with IC prepared from tetanus toxoid diluted 1:4 and 1:32. Because insoluble IC were noted after the overnight incubation in those tubes containing tetanus toxoid diluted 1:8 and 1:16, IC prepared from tetanus toxoid diluted 1:4 and 1:32 are referred to, respectively, as "relative antibody excess" and "relative antigen excess." [PRONASE], mg/ml FIGURE (12) . The protein was dialyzed against PBS and concentrated to 25-30 mg/ml. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed >95% disappearance of the IgG band, whereas a dominant F(ab')2 band appeared (13 We next asked whether IgG from serum of patients with SLE would bind to pronase-treated Raji cells. In the experiment described in Fig. 2 , using conditions identical to those in Fig. 1 To determine the size of the material in SLE serum that binds to pronase-digested Raji cells, we subjected two SLE sera to sucrose density gradient centrifugation and assayed the fractions for binding activity to Raji cells. Data from one of the patients is shown in Fig. 3 ; gradient fractions from the other patient gave Sera from three patients with SLE were incubated at 37°C with various numbers of pronase-digested (D) or undigested (U) Raji cells and were then evaluated for their ability to bind to pronase-digested Raji cells (D) as in Fig. 2 . The adsorption ratio of serum to 16 x 10" cells was identical to that used in the usual Raji assay, as was temperature and time of the adsorption incubation. (Table III) . Raji cells clearly bound pepsin-digested SLE IgG. This was most evident when the uptake of 125I-anti-Fab was studied. As expected, uptake of 125I-anti-Fcy by other aliquots of these same cells was much less marked, in contrast to the consistent superiority of 1251-anti-Fcy in the detection of the Raji cell-bound IgG from SLE serum. All four SLE pepsin digests showed similar data, whereas a pepsin digest of normal Ig showed no preferential detection by either anti-Fab or anti-Fey (Table III) Possibly, the particular Raji cell line that we are using is unusual in its ability to bind antibody from SLE patients. The data presented by Woodroffe et al. (9) suggest that it is not. Moreover, our cell line was obtained from the laboratory where the Raji assay was developed (1), and its characteristics have not changed substantially in our hands. It manifests complementdependent IC binding quite comparable with the original description of the Raji cells under conditions that do not differ significantly from those first described. We have surveyed other groups of patients to determine how our assay compares with published experience. The results indicate positive Raji cell binding with sera from patients with mixed connective tissue disease, various vasculitides, rheumatoid arthritis, scleroderma, subacute bacterial endocarditis, hyperglobulinemic purpura, and hepatitis. We believe that our overall results will not be too dissimilar from published reports.
Given data from other sources, it is not surprising to find IgG antilymphocyte antibody in SLE sera binding to Raji cells. Winfield et al. (6) indicated that most SLE sera contain antilymphocyte IgG that binds to 10-30% of the lymphocytes of all subjects tested. These antibodies have a somewhat greater specificity for B cells, the lineage of the Raji line, and they bind with equal facility at 37°C, the Raji assay temperature, as at 4°C. Searles et al. found antilymphocyte antibodies of all classes in SLE sera, although their antigenic substrate was acetone-fixed lymphocytes that likely bind not only membrane-directed antibody but antibody directed toward intracellular constituents as well (16) . Our own preliminary work indicates that several of the SLE sera described herein contain IgM and IgA that binds to Raji cells under the conditions of the assay. Work is in progress to define whether this material is antibody or IC or both.
Ifthese antibodies in SLE sera were directed against membrane constituents, the exact antigenic structures involved would be important to define. Prior incubation of untreated Raji cells with pepsin digests of SLE Ig did not inhibit subsequent binding of our model complement-fixed complexes (data not shown), indicating that the antibodies are probably not specific for the complement receptors. Other membrane determinants have been suggested as the specific binding sites for antilymphocyte antibody. For example, several workers have shown inhibition of the mixed lymphocyte reaction and antibody-dependent cell-mediated cytotoxicity with IgG antibodies from SLE patients (17) (18) (19) .
The results of this study compel us to urge caution in ascribing Raji positivity to the presence of circulating IC in patients with SLE.
